HealthCor Management’s Pfizer PFE Stock Holding History

HealthCor Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-242,880	Closed	-$12.6M	–	70
2022 Q1	$12.6M	Sell	242,880 -96,230	-28%	-$4.99M	0.84%	35
2021 Q4	$20M	Buy	+339,110	New	+$16.8M	1.09%	31
2017 Q4	–	Sell	-260,939	Closed	-$8.84M	–	39
2017 Q3	$8.84M	Buy	+260,939	New	+$8.39M	0.3%	38
2016 Q2	–	Sell	-1,686,400	Closed	-$47.4M	–	48
2016 Q1	$47.4M	Buy	1,686,400 +31,483	+2%	+$899K	2.69%	15
2015 Q4	$50.7M	Sell	1,654,917 -1,164,533	-41%	-$36.6M	3.08%	14
2015 Q3	$84M	Buy	+2,819,450	New	+$90.4M	4.73%	6
2015 Q2	–	Sell	-973,053	Closed	-$32.1M	–	71
2015 Q1	$32.1M	Sell	973,053 -2,419,878	-71%	-$76.9M	1.53%	28
2014 Q4	$100M	Buy	+3,392,931	New	+$97.3M	5.59%	3
2014 Q2	–	Sell	-316,200	Closed	-$9.64M	–	64
2014 Q1	$9.64M	Buy	+316,200	New	+$9.43M	0.58%	37
2013 Q4	–	Sell	-248,217	Closed	-$6.76M	–	63
2013 Q3	$6.76M	Buy	+248,217	New	+$6.75M	0.36%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HealthCor Management's PFE Position: Q2 2022 in Review

HealthCor Management sold out of Pfizer (PFE) in Q2 2022, closing a stake of 242,880 shares — an estimated $12.6M sold.

HealthCor Management first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $100M in Q4 2014. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

HealthCor Management reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
HealthCor Management sold 242,880 Pfizer shares in Q2 2022, an estimated $12.6M.
HealthCor Management first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
HealthCor Management's Pfizer position peaked at $100M in Q4 2014.
3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.